BETH DECKARD: Open Payments
NPI 1619916111 · SELINSGROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 28 payments from 12 companies in 2025. Trend: 2023 $1,279 · 2024 $1,494 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $147 |
| Lilly USA, LLC | 4 | $66 |
| ABBVIE INC. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Astellas Pharma US Inc | 1 | $30 |
| Exact Sciences Corporation | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
Products named: Ozempic, JARDIANCE, LEQVIO, QULIPTA, Veozah, The Cologuard Plus Collection Kit, Wegovy, Kerendia.
Industry payments across PA — which companies pay providers there.
